Effects of direct thrombin or factor Xa inhibition on clot thrombogenicity in vitro: comparison of dabigatran with rivaroxaban and apixaban

被引：0
|
作者：
van Ryn, J. [1 ]
Kink-Eiband, M. [1 ]
Kuritsch, I [1 ]
Wienen, W. [2 ]
机构：
[1] Boehringer Ingelheim GmbH & Co KG, Drug Discovery Support, Biberach, Germany
[2] Boehringer Ingelheim GmbH & Co KG, Pulm Res, Biberach, Germany
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-WE-181
引用
收藏
页码：687 / 688
页数：2
相关论文
共 50 条
  • [31] Comparison of the effect of the anti-Xa direct oral anticoagulants apixaban, edoxaban, and rivaroxaban on coagulation assays
    Gosselin, R.
    Grant, R. P.
    Adcock, D. M.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2016, 38 (05) : 505 - 513
  • [32] Direct Rivaroxaban-Induced Factor XA Inhibition Proves to be Cardioprotective in Rats
    Guillou, Sophie
    Beaumont, Justine
    Tamareille, Sophie
    Giraud, Sebastien
    Mirebeau-Prunier, Delphine
    Prunier, Fabrice
    Macchi, Laurent
    SHOCK, 2020, 53 (06): : 730 - 736
  • [33] Rivaroxaban: direct factor Xa inhibition to treat acute deep vein thrombosis
    Fassiadis, Nicholas
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2011, 72 (09) : 486 - 486
  • [34] Factor Xa inhibition by rivaroxaban in the trough steady state can significantly reduce thrombin generation
    Horinaka, Shigeo
    Sugawara, Rie
    Yonezawa, Yutaka
    Ishimitsu, Toshihiko
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (01) : 79 - 87
  • [35] Effects of direct factor Xa inhibitor, YM150 on clot formation and clot lysis In vitro compared with other anticoagulants
    Kaku, Seiji
    Suzuki, Ken-Ichi
    Funatsu, Toshiyuki
    Saitoh, Minori
    Koshio, Hiroyuki.
    Ishihara, Tsukasa
    Hirayama, Fukushi
    Kawasaki, Tomihisa
    BLOOD, 2007, 110 (11) : 927A - 927A
  • [36] SYSTEMATIC ASSESSMENT OF THE EFFECT OF DIRECT ORAL ANTICOAGULANTS DABIGATRAN, RIVAROXABAN AND APIXABAN USING CALIBRATED AUTOMATED THROMBIN GENERATION ASSAY IN VIVO
    Artang, Ramin
    Anderson, Maren
    Riley, Paul
    Nielsen, Joern Dalsgaard
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 768 - 768
  • [37] Comparison of the effects of heparin and the direct factor Xa inhibitor, rivaroxaban, on bone microstructure and metabolism in adult rats
    Xia, Jingjun
    Zhang, Zhipeng
    Wang, Jialiang
    Zu, Jianing
    Wang, Nanxiang
    Wang, Duanyang
    CONNECTIVE TISSUE RESEARCH, 2015, 56 (06) : 477 - 482
  • [38] Comparative Effects of the Direct Factor Xa Inhibitor, Apixaban, and the Direct Inhibitors of Factor VIIa, XIa and Thrombin on Tissue Factor-Induced Human Platelet Aggregation.
    Jiang, Xiaosui
    Wong, Pancras C.
    BLOOD, 2008, 112 (11) : 704 - 705
  • [39] Heparin-Calibrated Anti-Factor Xa Assay for the Measurement of Direct Anticoagulants such as Apixaban, Rivaroxaban, and Edoxaban
    Ahn, Hyo-Suk
    Chae, Hyojin
    Kim, Yeongsic
    Lee, Hey Kyung
    Kim, Hyunjung
    CLINICAL LABORATORY, 2024, 70 (09) : 1682 - 1689
  • [40] The effect of andexanet alfa on the pharmacokinetics and renal clearance of the direct factor Xa inhibitors apixaban, rivaroxaban, edodoxaban and betrixaban
    Leeds, J. M.
    Lu, G.
    Kwok, E.
    Farmer, J.
    Castillo, J.
    Mathur, V
    Bronson, M. D.
    Curnutte, J. T.
    Conley, P. B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 : 11 - 11
12345